Relmada Therapeutics Inc.

RLMD | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.22

+$0.06 (+1.44%)

Sep 22, 2026, 1:31 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	3.5M	3.86M	4.09M	5.4M	44.44M	2.5M
Short-Term Investments	89.51M	41.05M	92.23M	142.93M	167.47M	114.6M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	19.5K	21.98K	43.13K	34.88K	28.29K	111.38K
Receivables	n/a	n/a	n/a	512.43K	86.38K	79.46K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a	n/a	35	-10
Total Current Assets	93.98M	45.8M	97.51M	152.87M	223.3M	118.07M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	1.26K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	19.5K	21.98K	43.13K	34.88K	28.29K	112.64K
Total Assets	94M	45.82M	97.55M	152.91M	223.33M	118.19M
Account Payables	1.57M	4.13M	3.51M	5.26M	11.19M	8.35M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	535.48K	1.15M	5.68M	1.02M	1.64M	1.8M
Total Current Liabilities	6.43M	10.29M	12.19M	12.47M	15.06M	12.6M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	1.06M	4.47K	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	1.06M	4.47K	n/a	n/a	n/a	n/a
Total Liabilities	7.49M	10.3M	12.19M	12.47M	15.06M	12.6M
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a
Book Value	86.51M	35.52M	85.36M	140.44M	208.26M	105.58M
Book Value Per Share	2.19	1.18	2.84	4.74	11.87	6.77
Common Stock	73.33K	30.17K	30.1K	30.1K	27.74K	16.33K
Retained Earnings	-698.27M	-640.88M	-560.9M	-462.11M	-305.07M	-179.32M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	86.51M	35.52M	85.36M	140.44M	208.26M	105.58M
Total Investments	89.51M	41.05M	92.23M	142.93M	167.47M	114.6M